• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在胃癌中,微小RNA-646通过靶向FOXK1抑制细胞增殖和上皮间质转化诱导的转移。

MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.

作者信息

Zhang P, Tang W M, Zhang H, Li Y Q, Peng Y, Wang J, Liu G N, Huang X T, Zhao J J, Li G, Li A M, Bai Y, Chen Y, Ren Y X, Li G X, Wang Y D, Liu S D, Wang J D

机构信息

Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Department of Gastroenterology, Hexian Memorial Affiliated Hospital of Southern Medical University, Guangzhou 511400, China.

出版信息

Br J Cancer. 2017 Aug 8;117(4):525-534. doi: 10.1038/bjc.2017.181. Epub 2017 Jun 20.

DOI:10.1038/bjc.2017.181
PMID:28632723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5558677/
Abstract

BACKGROUND

MiR-646 has been reported to be aberrantly expressed in human cancers. However, the underlying molecular mechanisms of action of miR-646 in gastric cancer (GC) have not yet been investigated.

METHODS

In vitro function of miR-646 in GC was evaluated using EdU assay, plate colony formation assay, and matrigel invasion assay. Real-time PCR or western blotting was performed to detect miR-646 and FOXK1 expressions. In vivo tumour growth and metastasis were conducted in nude mice.

RESULTS

MiR-646 expression was downregulated in GC tissues compared with adjacent normal tissues. Low miR-646 expression is associated with malignant progression. Transient transfection of GC cells with miR-646 inhibited their growth and migration. Moreover, miR-646 influenced the expression of epithelial-mesenchymal transition (EMT)-associated proteins. TGF-β1 treatment significantly suppressed the expression of miR-646 and overexpression of this microRNA counteracted the influence of the TGF-β1-induced EMT phenotype. In terms of the underlying mechanism, miR-646 directly targeted FOXK1. In vivo, it inhibited the FOXK1-mediated proliferation and EMT-induced metastasis. Consistently, inverse correlations were also observed between the expression of miR-646 and FOXK1 in human GC tissue samples. Furthermore, miR-646 regulated Akt/mTOR signalling after FOXK1.

CONCLUSIONS

miR-646 inhibited GC cell proliferation and the EMT progression in GC cells by targeting FOXK1.

摘要

背景

据报道,miR-646在人类癌症中表达异常。然而,miR-646在胃癌(GC)中的潜在分子作用机制尚未得到研究。

方法

使用EdU检测、平板克隆形成检测和基质胶侵袭检测评估miR-646在GC中的体外功能。进行实时PCR或蛋白质印迹以检测miR-646和FOXK1的表达。在裸鼠中进行体内肿瘤生长和转移实验。

结果

与相邻正常组织相比,GC组织中miR-646的表达下调。低miR-646表达与恶性进展相关。用miR-646瞬时转染GC细胞可抑制其生长和迁移。此外,miR-646影响上皮-间质转化(EMT)相关蛋白的表达。TGF-β1处理显著抑制miR-646的表达,而这种 microRNA 的过表达抵消了TGF-β1诱导的EMT表型的影响。就潜在机制而言,miR-646直接靶向FOXK1。在体内,它抑制FOXK1介导的增殖和EMT诱导的转移。同样,在人类GC组织样本中也观察到miR-646和FOXK1表达之间呈负相关。此外,miR-646在FOXK1之后调节Akt/mTOR信号通路。

结论

miR-646通过靶向FOXK1抑制GC细胞增殖和GC细胞中的EMT进展。

相似文献

1
MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.在胃癌中,微小RNA-646通过靶向FOXK1抑制细胞增殖和上皮间质转化诱导的转移。
Br J Cancer. 2017 Aug 8;117(4):525-534. doi: 10.1038/bjc.2017.181. Epub 2017 Jun 20.
2
Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells.C-jun对FOXK1的直接调控促进胃癌细胞的增殖、侵袭和转移。
Cell Death Dis. 2016 Nov 24;7(11):e2480. doi: 10.1038/cddis.2016.225.
3
miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.miR-186-5p通过靶向FOXK1在人骨肉瘤中发挥肿瘤抑制作用。
Cell Physiol Biochem. 2019;52(3):553-564. doi: 10.33594/000000039.
4
MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.微小RNA-592通过靶向Sprouty2蛋白,经由PI3K/AKT和MAPK/ERK信号通路促进胃癌的增殖、迁移和侵袭。
Cell Physiol Biochem. 2018;47(4):1465-1481. doi: 10.1159/000490839. Epub 2018 Jun 21.
5
miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.微小RNA-204通过靶向锌指蛋白Snail1调控上皮-间质转化,从而抑制胃癌的侵袭和迁移。
Tumour Biol. 2016 Jun;37(6):8327-35. doi: 10.1007/s13277-015-4627-0. Epub 2016 Jan 5.
6
Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.微小RNA-204通过靶向转化生长因子β受体2介导的上皮-间质转化使胃癌细胞对5-氟尿嘧啶敏感
Cell Physiol Biochem. 2018;47(4):1533-1545. doi: 10.1159/000490871. Epub 2018 Jun 21.
7
Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.靶向 SPP1 的 microRNA-340 通过抑制 PI3K/AKT 信号通路抑制胃癌细胞上皮-间充质转化。
J Cell Physiol. 2019 Aug;234(10):18587-18601. doi: 10.1002/jcp.28497. Epub 2019 Apr 5.
8
MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.微小RNA-206通过c-Met/PI3k/Akt/mTOR信号通路抑制非小细胞肺癌中肝细胞生长因子诱导的上皮-间质转化和血管生成。
Oncotarget. 2016 Apr 5;7(14):18247-61. doi: 10.18632/oncotarget.7570.
9
Inhibiting Forkhead box K1 induces autophagy to reverse epithelial-mesenchymal transition and metastasis in gastric cancer by regulating Myc-associated zinc finger protein in an acidic microenvironment.在酸性微环境中,通过调节 Myc 相关锌指蛋白,抑制叉头框 K1 诱导自噬逆转胃癌上皮-间质转化和转移。
Aging (Albany NY). 2020 Apr 8;12(7):6129-6150. doi: 10.18632/aging.103013.
10
miR-1294 alleviates epithelial-mesenchymal transition by repressing FOXK1 in gastric cancer.miR-1294 通过抑制胃癌中的 FOXK1 缓解上皮-间充质转化。
Genes Genomics. 2020 Feb;42(2):217-224. doi: 10.1007/s13258-019-00899-3. Epub 2019 Dec 12.

引用本文的文献

1
Retraction Note: Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4.撤稿说明:长链非编码RNA CASC15通过表观遗传调控PDCD4促进黑色素瘤进展。
Cell Biosci. 2025 Aug 26;15(1):121. doi: 10.1186/s13578-025-01462-2.
2
Circular RNA Circ_0079226 Plays an Oncogenic Role in Gastric Cancer via the miR-155-5p/FOXK1/AKT Pathway.环状RNA Circ_0079226通过miR-155-5p/FOXK1/AKT通路在胃癌中发挥致癌作用。
Anal Cell Pathol (Amst). 2025 Feb 13;2025:6619550. doi: 10.1155/ancp/6619550. eCollection 2025.
3
Role of miRNA in Cardiovascular Diseases in Children-Systematic Review.

本文引用的文献

1
FOXK1 interaction with FHL2 promotes proliferation, invasion and metastasis in colorectal cancer.FOXK1与FHL2的相互作用促进结直肠癌的增殖、侵袭和转移。
Oncogenesis. 2016 Nov 28;5(11):e271. doi: 10.1038/oncsis.2016.68.
2
Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells.C-jun对FOXK1的直接调控促进胃癌细胞的增殖、侵袭和转移。
Cell Death Dis. 2016 Nov 24;7(11):e2480. doi: 10.1038/cddis.2016.225.
3
Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
miRNA 在儿童心血管疾病中的作用——系统评价。
Int J Mol Sci. 2024 Jan 12;25(2):956. doi: 10.3390/ijms25020956.
4
Discovery of novel microRNA mimic repressors of ribosome biogenesis.新型核糖体生物发生 microRNA 模拟物抑制剂的发现。
Nucleic Acids Res. 2024 Feb 28;52(4):1988-2011. doi: 10.1093/nar/gkad1235.
5
Forkhead box L2 is a target of miR-133b and plays an important role in the pathogenesis of non-small cell lung cancer.叉头框蛋白 L2 是 miR-133b 的靶标,在非小细胞肺癌的发病机制中发挥重要作用。
Cancer Med. 2023 Apr;12(8):9826-9842. doi: 10.1002/cam4.5746. Epub 2023 Feb 27.
6
miR-877-5p Inhibits Epithelial Mesenchymal Transformation of Breast Cancer Cells by Targeting FGB.miR-877-5p 通过靶向 FGB 抑制乳腺癌细胞的上皮间质转化。
Dis Markers. 2022 Nov 17;2022:4882375. doi: 10.1155/2022/4882375. eCollection 2022.
7
The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells.miR-3648/FRAT1-FRAT2/c-Myc 负反馈环调节胃癌细胞的转移和侵袭。
Oncogene. 2022 Oct;41(43):4823-4838. doi: 10.1038/s41388-022-02451-2. Epub 2022 Sep 24.
8
Genomic Analyses of Non-Coding RNAs Overlapping Transposable Elements and Its Implication to Human Diseases.非编码 RNA 与转座元件重叠的基因组分析及其对人类疾病的影响。
Int J Mol Sci. 2022 Aug 11;23(16):8950. doi: 10.3390/ijms23168950.
9
The Function of FoxK Transcription Factors in Diseases.FoxK转录因子在疾病中的作用。
Front Physiol. 2022 Jul 12;13:928625. doi: 10.3389/fphys.2022.928625. eCollection 2022.
10
Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.功能性筛选抑制人宫颈癌细胞锚定非依赖性生长的 microRNAs。
Int J Mol Sci. 2022 Apr 26;23(9):4791. doi: 10.3390/ijms23094791.
单独敲低FOXK1或与诱导凋亡的5-氟尿嘧啶联合使用可抑制结直肠癌细胞的生长。
Oncol Rep. 2016 Oct;36(4):2151-9. doi: 10.3892/or.2016.5041. Epub 2016 Aug 25.
4
MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.MicroRNA-132/212上调通过靶向SOX4抑制转化生长因子-β介导的前列腺癌细胞上皮-间质转化
Prostate. 2016 Dec;76(16):1560-1570. doi: 10.1002/pros.23241. Epub 2016 Aug 16.
5
miR-646 is a key negative regulator of EGFR pathway in lung cancer.miR-646是肺癌中表皮生长因子受体(EGFR)信号通路的关键负调控因子。
Exp Lung Res. 2016 Aug;42(6):286-95. doi: 10.1080/01902148.2016.1207726. Epub 2016 Jul 27.
6
Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.癌基因FOXK1通过诱导上皮-间质转化增强结直肠癌的侵袭能力。
Oncotarget. 2016 Aug 9;7(32):51150-51162. doi: 10.18632/oncotarget.9457.
7
miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression.miR-340与ZEB1负反馈回路调控转化生长因子-β介导的乳腺癌进展。
Oncotarget. 2016 May 3;7(18):26016-26. doi: 10.18632/oncotarget.8421.
8
Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.蟾毒灵通过PI3K/AKT/mTOR途径靶向缺氧诱导因子-1α(HIF-1α)来抑制肝细胞癌的侵袭和转移。
Oncotarget. 2016 Apr 12;7(15):20193-208. doi: 10.18632/oncotarget.7935.
9
Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.表观遗传沉默的miR-124的重新激活通过直接抑制IQGAP1的表达来逆转子宫内膜癌细胞的上皮-间质转化并抑制其侵袭。
Oncotarget. 2016 Apr 12;7(15):20260-70. doi: 10.18632/oncotarget.7754.
10
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.微小RNA-15a和微小RNA-16在卵巢癌中的治疗评估
Oncotarget. 2016 Mar 22;7(12):15093-104. doi: 10.18632/oncotarget.7618.